H-Cys(Acm)-NH2.HCl, 1g

(S)-2-(1-Aminoethyl)phenol, 95%, 1g

1-(O-tolyl)urea, 98%, 5g

N-(Piperidin-4-yl)morpholine-4-carboxamide hydrochloride, 95.0%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-2-phenylacetic acid, 95.0%, 25g

2-Morpholino-3-(trifluoromethyl)pyridine-5-boronic acid, 98%, 1g

Ginsenoside Rg1>95.0%(HPLC)25mg

Methyl 5-aminopyrimidine-4-carboxylate, 95%, 500mg

(R)-1-(6-METHOXYPYRIDIN-3-YL)ETHANAMINE HCL, 95%, 1g

TRibutylmethylphosphonium bis(trifluoromethanesulfonyl)imide, 98%, 5g

1-(4-Bromophenyl)cyclopentanecarbonitrile, 95.0%, 10g

6-ethyl-N-(pyridin-3-ylmethyl)-1,3-benzothiazol-2-amine, 95.0%, 250mg

GC capillary column ROTI®Cap-1701, 25 m, 0.32 mm, 0.25 µm, 1 Piece(s)